0709T Id ca immntx each additional njx
Also known as: Immunotherapy additional injections, Subsequent immune therapy, Cancer immunotherapy continuation
Identification of cancer immunotherapy patient candidates with each additional injection.
In Plain Language
Follow-up immune therapy treatments for cancer; Additional doses of immunotherapy
Clinical Context
Subsequent injections of immunotherapy in identified candidate patients continuing active treatment protocol.
RVU Information
CPT 0709T does not have a physician work RVU assigned by CMS. Category III codes for emerging technology do not receive RVU assignments. Reimbursement is negotiated with individual payers.
Billing & Documentation
Category III codes are temporary codes for emerging technology, services, and procedures. They are not assigned RVU values by CMS. Coverage and reimbursement vary by payer — check with individual insurers before billing. These codes sunset after 5 years if not converted to Category I.
Specialties
Frequently Asked Questions
What is CPT code 0709T?
CPT 0709T (Id ca immntx each additional njx) is a Category III code. Identification of cancer immunotherapy patient candidates with each additional injection.
Is 0709T a permanent CPT code?
No — 0709T is a Category III temporary code for emerging technology. It may be converted to a permanent Category I code if widely adopted. Category III codes expire after 5 years without renewal.
When is CPT 0709T used?
Subsequent injections of immunotherapy in identified candidate patients continuing active treatment protocol.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.